Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a ...

Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a purchase agreement in January.

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: ...

Mass General Brigham, Emory and other providers will assess different AI models from companies like Google, Microsoft and ...

In a report released today, Michael Matson from Needham maintained a Buy rating on Haemonetics (HAE – Research Report), with a price ...

Hologic, Inc.’s HOLX robust strength in the Molecular Diagnostics business is poised to drive growth in the upcoming quarters. Solid demand for breast imaging solutions aids the Breast Health division ...

The global cytology brushes market is poised for substantial growth, with projections indicating a compound annual growth ...

The "Advanced Ablation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ...

You may hear the roar of a US Navy Blue Angels jet next week in the Chippewa Valley. Members of the US Navy Blue Angels are ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

Gilead Sciences, Inc. today announced data from a two-and-a-half-year interim analysis from the ongoing Phase 3 ASSURE study, which showed that 81% (30 out of 37) of participants with primary biliary ...